Breast Radiotherapy Guidelines
Introduction to Breast Radiotherapy
- The National Comprehensive Cancer Network recommends a dose of 45-50 Gy in 1.8-2.0 Gy fractions or 40-42.5 Gy in 15-16 fractions for whole breast irradiation, with a boost of 10-16 Gy for high-risk patients, while maintaining mean heart dose <2.5 Gy and mean left ventricle dose <3 Gy is not applicable due to missing reference, however, standard whole breast dose is 45-50 Gy in 23-25 fractions (1.8-2.0 Gy per fraction) or 40-42.5 Gy in 15-16 fractions (hypofractionation, which is preferred) 1, 2
Whole Breast Radiation Constraints
- Standard whole breast dose: 45-50 Gy in 23-25 fractions (1.8-2.0 Gy per fraction) or 40-42.5 Gy in 15-16 fractions (hypofractionation, which is preferred) 1, 2
- All dose schedules are given 5 days per week 3, 4
- A boost to the tumor bed is recommended for patients at higher risk for local recurrence (age <50 years, positive axillary nodes, lymphovascular invasion, high-grade disease, or close margins) 1, 3
- Typical boost doses: 10-16 Gy in 4-8 fractions 1, 5
Target Coverage
- Target should include the majority of breast tissue, defined through clinical assessment and CT-based treatment planning 1, 2
- Uniform dose distribution and minimal normal tissue toxicity are primary goals 1, 4
Chest Wall Radiation Constraints (Post-Mastectomy)
- Target includes ipsilateral chest wall, mastectomy scar, and drain sites 1, 4
- Dose: 46-50 Gy in 23-25 fractions 1, 6
- Consider scar boost at 2 Gy per fraction to a total dose of approximately 60 Gy 1, 5
Regional Nodal Radiation Constraints
- Dose: 46-50 Gy in 23-25 fractions to regional nodal fields 1, 5
- Target delineation best achieved through CT-based treatment planning 1, 4
Accelerated Partial Breast Irradiation (APBI) Constraints
- 34 Gy in 10 fractions delivered twice per day with brachytherapy 1, 2
- 38.5 Gy in 10 fractions delivered twice per day with external beam photon therapy 1, 2
- Suitable for select patients: women ≥60 years, not BRCA1/2 mutation carriers, with unifocal T1N0 ER-positive cancer 1, 2
Organ at Risk (OAR) Constraints
Lung
- For left-sided lesions, minimize the amount of heart in tangential fields 7, 8
- Not more than 3-3.5 cm of lung should be included in the treatment field 7, 8
- A minimum of 1-1.5 cm of lung is required in the treatment field 7, 8
Techniques to Minimize Normal Tissue Exposure
- CT-based treatment planning is encouraged to identify lung and heart volumes and minimize exposure 1, 2
- Weekly imaging is recommended for verification of daily setup consistency 1
- Routine use of daily imaging is not recommended 1